Dr James Whiteford

Profile

James Whiteford graduated in Applied Biology from King’s College London in 1994 and obtained his PhD from King’s College London in 1998. Following post-doctoral research at Imperial College London and Copenhagen University (Denmark) he joined the Centre for Microvascular Research and was awarded an Arthritis Research UK career development fellowship in 2009. He obtained his Lectureship at the William Harvey Research Institute in 2014, and obtained his Senior Lectureship in 2016.

Memberships and Awards

• Chairman London Matrix Biology Group
• BSMB Organising Committee Member
• Editor British Journal of Pharmacology
• Editor Pharmacology Research and Perspectives
• Editor Frontiers in Immunology

Research

Summary

Group members

Publications

• Arokiasamy S, Balderstone MJM, Shaik F et al. (2024). QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age‐related macular degeneration.

  
  

  DOI: 10.1111/bph.17362

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100742
• mohamed M, WHITEFORD J, fan S (2024). WCN24-1216 CHARACTERISATION AND MODULATION OF GUT MICROBIOTA IN A MULTIETHNIC DIALYSIS COHORT USING THE BARTS DIABETIC KIDNEY CENTRE BIOBANK: A FEASIBILITY AND PILOT STUDY.

  
  

  DOI: 10.1016/j.ekir.2024.02.1234

  
  

  QMRO:
• Moss BJ, McKenna N, Ochsner S et al. (2023). Regulation of Senescence and Mitochondrial Function by CD148 in Idiopathic Pulmonary Fibrosis Alveolar Epithelial Cells. A107. AGING AND LUNG DISEASES COMING TO AGE

  
  

  DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2665

  
  

  QMRO:
• Mauro D, Manou-Stathopoulou S, Rivellese F et al. (2023). UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus.

  
  

  DOI: 10.1016/j.jaut.2023.103023

  
  

  QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/85700
• Weeraman D, Jones DA, Hussain M et al. (2023). Proangiogenic Growth Factor Therapy for the Treatment of Refractory Angina: A Meta-analysis.

  
  

  DOI: 10.1016/j.jscai.2022.100527

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/88688
• Joulia R, Guerrero-Fonseca IM, Girbl T et al. . Neutrophil breaching of the blood vessel pericyte layer during diapedesis requires mast cell-derived IL-17A.

  
  

  DOI: 10.1038/s41467-022-34695-7

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82420
• Whiteford J, Arokiasamy S, Thompson CL et al. (2022). Novel application of live imaging to determine the functional cell biology of endothelial-to-mesenchymal transition (EndMT) within a liver-on-a-chip platform.

  
  

  DOI: 10.1007/s44164-022-00034-9

  
  

  QMRO:
• Whiteford J, Arokiasamy S, Thompson C et al. (2022). FRI198 Investigating the function of Endothelial-To-Mesenchymal transition during liver fibrogenesis using a Liver-On-A-Chip platform.

  
  

  DOI: 10.1016/s0168-8278(22)01308-3

  
  

  QMRO:
• Moss BJ, Ebrahimpour A, Coarfa C et al. (2022). CD148 Loss-of-Function Promotes Cellular Senescence and the Development of Experimental Fibrosis. C29. SENESCENCE, SENOLYTICS, AND AGING IN LUNG BIOLOGY

  
  

  DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3895

  
  

  QMRO:
• Thorup A-S, Wilson J, Strachan D et al. (2022). BLOCKING ROR2 IMPROVES CARTILAGE INTEGRITY AND PROVIDES PAIN RELIEF IN OSTEOARTHRITIS, IN PART BY MODULATING YAP SIGNALLING.

  
  

  DOI: 10.1016/j.joca.2022.02.201

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95161

Collaborators

• Dr Tero Järvinen (University of Tampere, Finland)
• Prof James Bainbridge (UCL, UK)

News

November 2015

• Male and female mice respond differently to inflammation (EurekAlert)

Teaching

• Module Lead on BMD211 Pharmacology and IT BSc Degree Programme
• BMD175 ‘Research Skills for Pharmacologists’